Cite
HARVARD Citation
Shinde, A. et al. (2019). Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio. Lung cancer. pp. 136-143. [Online].